SLT (Selective Laser Trabeculoplasty) is a safe and straight-forward office laser treatment that effectively significantly reduces the pressure in the eye for most patients with glaucoma. The SLT uses an advanced laser to target only certain specific cells of the eye  ie those containing melanin, a natural pigment found in the trabecular meshwork. This area is the region where fluid drains out of the eye. Laser treatment applied to this area can increase the drainage out, lowering eye pressure. Previously laser applied to achieve this effect required high energy powers, whereas SLT involves far less power to achieve gentle control of IOP. SLT is akin to "dusting" the trabecular meshwork - ie wiping the surface clean gently.

Features of SLT:

Safe usage record:

SLT is not associated with systemic side effects or the compliance and cost issues of medications.

Selective application: using selective photothermolysis SLT targets specific cells, leaving the surrounding tissue intact.

Smart mechanism of action:  SLT stimulates natural mechanisms to lower eye pressure.

Sensible treatment of choice: SLT therapy is reimbursed by many insurance providers.

Vision loss from glaucoma is permanent but can usually be prevented with early detection and treatment. Glaucoma management is usually a lifelong process that requires frequent monitoring and constant treatment. Since there is no way to determine if glaucoma is under control based on how a person feels, doctor visits should be on a regular basis.

Advanced field loss in glaucoma (Visual field testing)